Cutaneous porphyrias part II: treatment strategies

被引:14
|
作者
Tintle, Suzanne [1 ]
Alikhan, Ali [2 ]
Horner, Mary E. [3 ]
Hand, Jennifer L. [2 ,4 ,5 ]
Davis, Dawn Marie R. [2 ,4 ]
机构
[1] Tufts Med Ctr, Dept Dermatol, Boston, MA USA
[2] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA
[3] Baylor Univ, Med Ctr, Dept Dermatol, Dallas, TX USA
[4] Mayo Clin, Dept Pediat, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Med Genet, Rochester, MN 55905 USA
关键词
CONGENITAL ERYTHROPOIETIC PORPHYRIA; CHRONIC HEPATITIS-C; BONE-MARROW-TRANSPLANTATION; MELANOCYTE-STIMULATING HORMONE; ACUTE INTERMITTENT PORPHYRIA; LONG-TERM TREATMENT; ADENOSYL-L-METHIONINE; ORTHOTOPIC LIVER-TRANSPLANTATION; DOSE CHLOROQUINE TREATMENT; STEM-CELL TRANSPLANTATION;
D O I
10.1111/ijd.12016
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The porphyrias are diverse in pathophysiology, clinical presentation, severity, and prognosis, presenting a diagnostic and therapeutic challenge. Although not easily curable, the dermatological manifestations of these diseases, photosensitivity and associated cutaneous pathology, can be effectively prevented and managed. Sun avoidance is essential, and patient education regarding the irreversibility of photocutaneous damage is a necessary corollary. Beyond preventative measures, the care of fragile, vulnerable skin, and pain management, each of the porphyrias has a limited number of unique additional therapeutic options. Many of the treatments have been published only in small case series or anecdotal reports and do not have well-understood nor proven mechanisms of action. This article presents a comprehensive review of available therapeutic options and long-term management recommendations for the cutaneous porphyrias.
引用
收藏
页码:3 / 24
页数:22
相关论文
共 50 条
  • [1] Treatment of the cutaneous porphyrias
    Mathews-Roth, MM
    [J]. CLINICS IN DERMATOLOGY, 1998, 16 (02) : 295 - 298
  • [2] The cutaneous porphyrias
    Cuny, J-F
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2019, 146 (02): : 143 - 159
  • [3] The Cutaneous Porphyrias
    Schulenburg-Brand, Danja
    Katugampola, Ruwani
    Anstey, Alexander V.
    Badminton, Michael N.
    [J]. DERMATOLOGIC CLINICS, 2014, 32 (03) : 369 - +
  • [4] The cutaneous porphyrias
    Cohen, JL
    Lim, HW
    [J]. CURRENT PROBLEMS IN DERMATOLOGY-US, 2000, 12 (01): : 35 - 40
  • [5] The cutaneous porphyrias
    Lim, HW
    Cohen, JL
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1999, 18 (04) : 285 - 292
  • [6] THE CUTANEOUS PORPHYRIAS
    ELDER, GH
    [J]. SEMINARS IN DERMATOLOGY, 1990, 9 (01): : 63 - 69
  • [7] Cutaneous Porphyrias
    Koestler, E.
    Wollina, U.
    [J]. AKTUELLE DERMATOLOGIE, 2005, 31 (04) : 138 - 143
  • [8] CUTANEOUS PORPHYRIAS
    ZIEGLER, G
    [J]. THERAPEUTISCHE UMSCHAU, 1982, 39 (03) : 184 - 188
  • [9] Manifestations and Treatment of Cutaneous Lupus Erythematosus (Part II of II)
    Schairer, David
    Friedman, Adam
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (12) : 1474 - 1476
  • [10] MANAGEMENT OF THE CUTANEOUS PORPHYRIAS
    PERROT, H
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1982, 109 (02): : 183 - 187